Barron’s: CIO Bill Smead discusses the Pfizer / AstraZeneca deal
Pfizer a Buy as it Halts Pursuit of AstraZeneca By Teresa Rivas For more information go to www.barrons.com. The information contained in this article represents SCM’s opinions, and should not be construed as personalized or individualized investment advice. Past performance is no guarantee of future